EP1255580A2 — Housing for an inhaler
Assigned to Glaxo Group Ltd · Expires 2002-11-13 · 24y expired
What this patent protects
There is provided a housing for a dispenser suitable for dispensing medicament, particularly for use in the treatment of respiratory disorders. The housing comprises a body; said body including a support for receipt of said aerosol container; a first outlet port connectable to a …
USPTO Abstract
There is provided a housing for a dispenser suitable for dispensing medicament, particularly for use in the treatment of respiratory disorders. The housing comprises a body; said body including a support for receipt of said aerosol container; a first outlet port connectable to a first pressure recorder for recording change of pressure on firing of said aerosol container; and a second outlet port connectable to a second pressure recorder for recording air pressure within the body; wherein said first outlet port and said second outlet port are separate such that the change of pressure on firing and the air pressure within the body are individually recordable.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.